Granules India Overview

  • Founded
  • 1984

Founded
  • Status
  • Public

  • Employees
  • 5,427

Employees
  • Stock Symbol
  • 532482

Stock Symbol
  • Investments
  • 4

  • Share Price
  • $3.90

  • (As of Friday Closing)

Granules India General Information

Description

Granules India Ltd is an India-based pharmaceutical company. The company manufactures active pharmaceutical ingredients, pharmaceutical formulation intermediates and finished dosages. Its business is organized into three areas; the Core business which comprises core molecules such as Paracetamol, Ibuprofen, Metformin, Guaifenesin, and Methocarbamol; the Emerging business that focuses on manufacturing APIs and the US Generics. Its primary geographic markets are North America, Latin America, Europe, India, and Rest of World.

Contact Information

Formerly Known As
Triton Laboratories
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Stock Exchange
BOM
Primary Office
  • 2nd Floor, 3rd Block
  • My Home Hub, Madhapur
  • Hyderabad, Telengana 500081
  • India
+91 040 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Granules India Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.90 $3.88 $2.91 - $5.05 $963M 248M 88.5K $0.22

Granules India Financials Summary

In Thousands,
USD
TTM 30-Jun-2022 FY 2022 31-Mar-2022 FY 2021 31-Mar-2021 FY 2020 31-Mar-2020
EV 940,246 1,084,535 1,092,121 587,844
Revenue 517,144 500,241 429,575 358,229
EBITDA 95,913 96,046 116,004 84,923
Net Income 55,754 55,398 73,852 47,206
Total Assets 595,147 505,604 428,051
Total Debt 0 145,897 115,624 118,284
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Granules India Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Granules India‘s full profile, request access.

Request a free trial

Granules India Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Granules India Ltd is an India-based pharmaceutical company. The company manufactures active pharmaceutical ingredients,
Pharmaceuticals
Hyderabad, India
5,427 As of 2022
000.00
000000000000

000000

m, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irur
000000000000000
Hyderabad, India
0000 As of 0000

00000

do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud
000000000000000
Mumbai, India
0000 As of 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Granules India Competitors (11)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Neuland Laboratories Corporation Hyderabad, India 0000
00000 00000 Corporation Mumbai, India 0000
000000 000000 0000 Corporation Chennai, India 0000 000.00 000000000 000.00
0000000 000000 Private Equity-Backed New Delhi, India 00000 00000 0000000 0000 00000
00000 000000 Corporation Hyderabad, India 0000 000.00 0000 000.00
You’re viewing 5 of 11 competitors. Get the full list »

Granules India Patents

Granules India Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20180009790-A1 An improved process for the preparation of hcv inhibitor Abandoned 24-Dec-2014 0000000000
US-10385006-B2 Process for the preparation of amino alcohol derivatives or salts thereof Active 27-Oct-2014 0000000000
US-20170233329-A1 Process for the preparation of amino alcohol derivatives or salts thereof Granted 27-Oct-2014 0000000000
CA-2946101-A1 An improved process for the preparation of rifamycin derivatives Abandoned 19-Apr-2014 0000000000
EP-3134415-A2 An improved process for the preparation of rifamycin derivatives Withdrawn 19-Apr-2014 C07D498/22
To view Granules India’s complete patent history, request access »

Granules India Executive Team (11)

Name Title Board Seat Contact Info
Kandiraju Rao Chief Executive Officer & Managing Director
Sandip Neogi Chief Financial Officer
Guntamukkala Prasad Chief Operating Officer
Krishna Chigurupati Founder, Chairman & Managing Director
Atul Dhavle Chief Human Resources Officer & Head of Operational Excellence
You’re viewing 5 of 11 executive team members. Get the full list »

Granules India Board Members (4)

Name Representing Role Since
0000000 00000000000 Granules India Founder, Chairman & Managing Director 000 0000
You’re viewing 1 of 4 board members. Get the full list »

Granules India Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Granules India Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Granules India‘s full profile, request access.

Request a free trial

Granules India Investments & Acquisitions (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 14-Jul-2016 000000000 Pharmaceuticals 0000000 0
00000000-0000 20-Feb-2015 00000 0000 0000 Pharmaceuticals
000000 000000 14-Feb-2014 0000000000 000.00 Pharmaceuticals 0000000 0
Granules Biocause Pharmaceuticals 06-Mar-2007 Joint Venture Drug Discovery
To view Granules India’s complete investments and acquisitions history, request access »

Granules India Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000000-00000000 20-Feb-2015 00000 0000000 0000 Completed
  • 2 buyers
Granules Biocause Pharmaceuticals 06-Mar-2007 Joint Venture Completed
  • 2 buyers
To view Granules India’s complete exits history, request access »